NEXIGEN GMBH has a total of 11 patent applications. Its first patent ever was published in 2007. It filed its patents most often in EPO (European Patent Office), Canada and Australia. Its main competitors in its focus markets biotechnology, pharmaceuticals and measurement are WUHAN INST OF BIOLOGICAL PRODUCTS CO LTD, INDIAN IMMUNOLOGICALS LTD and SHENZHEN CENTER FOR DISEASE CONTROL AND PREVENTION SHENZHEN HEALTH INSPECTION CENTER SHENZHEN INST O.
# | Country | Total Patents | |
---|---|---|---|
#1 | EPO (European Patent Office) | 4 | |
#2 | Canada | 3 | |
#3 | Australia | 2 | |
#4 | Israel | 2 |
# | Industry | |
---|---|---|
#1 | Biotechnology | |
#2 | Pharmaceuticals | |
#3 | Measurement |
# | Technology | |
---|---|---|
#1 | Microorganisms | |
#2 | Medical preparations | |
#3 | Therapeutic chemical compounds | |
#4 | Peptides | |
#5 | Analysing materials |
# | Name | Total Patents |
---|---|---|
#1 | Hennemann Hanjo | 9 |
#2 | Friebe Annette | 6 |
#3 | Carl Claudia | 5 |
#4 | Wirths Sabine | 4 |
#5 | Kruse Claudia | 4 |
#6 | Schuermann Nina | 3 |
#7 | Hanke Sabine | 3 |
#8 | Hennemann Hanjo Dr | 1 |
#9 | Carl Claudia Dr | 1 |
#10 | Friebe Annette Dr | 1 |
Publication | Filing date | Title |
---|---|---|
AU2010280981A1 | Human HCV-interacting proteins and methods of use | |
AU2007291448A1 | Methods for detecting protein-peptide interactions | |
EP2025750A1 | Targets and compounds for therapeutic intervention of HIV infection |